Ligand Pharmaceuticals
Price & Volume
Stats
See moreOpen | $122.06 |
Previous Close | $122.01 |
Day Range | $119.25-$122.06 |
52W Range | $67.72-$129.90 |
Market Cap | $2.3B |
Shares Short | 951,520 |
Financials
See moreRevenue (12 Mos) | $152.4M |
Revenue Growth (YoY) | 57.6% |
Gross Profit (12 Mos) | $120M |
Diluted EPS | $2.49 |
News
See moreYahoo Finance • 6 months ago
Roth analysis: Has volatility created a trigger warning for stocks?
Yahoo Finance • 8 months ago
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
Yahoo Finance • 10 months ago
Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023)
About
CEO | Mr. Scott M. Plesha |
Address | 555 Heritage Drive, Jupiter, FL, United States, 33458 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 58 |
